UMN Pharma Inc. announced consolidated and non-consolidated earnings results for the year ended December 31, 2015. For the full year, on consolidated basis, the company announced net sales of JPY 202 million against JPY 1,108 million a year ago. Operating loss was JPY 3,207 million against JPY 3,942 million a year ago. Ordinary loss was JPY 3,390 million against JPY 4,249 million a year ago. Net income was JPY 3,390 million or JPY 354.16 per basic share against JPY 3,961 million or JPY 452.34 per basic share a year ago. Loss before income taxes and minority interests was JPY 3,390.038 million against JPY 4,002.394 million a year ago. Net cash used in operating activities was JPY 3,393 million against net cash provided by operating activities of JPY 314 million a year ago. Purchases of property, plant and equipment was JPY 407.064 million compared to JPY 5.004 million for the same period a year ago. Purchase of intangible assets was JPY 2.600 million compared to JPY 3.306 million for the same period a year ago.

For the full year, on non-consolidated basis, the company announced net sales of JPY 190 million against JPY 1,108 million a year ago. Operating loss was JPY 709 million against JPY 2,861 million a year ago. Ordinary loss was JPY 614 million against JPY 2,820 million a year ago. Net loss was JPY 617 million or JPY 64.48 per basic share against JPY 2,822 million or JPY 322.29 per basic share a year ago.